What We're Reading: Page 22
Industry reads hand-picked by our editors
Feb 05, 2025
-
Axios
Trump tariffs may play havoc with health prices, supply chains
-
The Wall Street Journal
Merck Is Suffering From a Classic Pharma Problem
-
Financial Times
Pfizer CEO ‘disappointed’ by Robert Kennedy’s refusal to rebut claims on vaccine risks
-
AP News
A spine-zapping implant helped 3 people with a muscle-wasting disease walk better
Feb 04, 2025
Feb 03, 2025
Jan 31, 2025
-
AP News
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
-
Financial Times
AstraZeneca ditches plan to build £450mn UK vaccine plant
-
Bloomberg
NHS Rolls Out £1.7 Million Gene Therapy for Sickle Cell Disease
-
KFF Health News
Trump Administration’s Halt of CDC’s Weekly Scientific Report Stalls Bird Flu Studies
Jan 30, 2025
-
The Wall Street Journal
Roche Expects Sales, Earnings Growth After Better-Than-Expected Results
-
KFF Health News
Telehealth Companies Boost Ad Spending While Taking on More Complex Medicine
-
Fierce Biotech
Inhibikase hits pause on Parkinson’s program over efficacy
Jan 29, 2025
-
The New York Times
State Department Permits Distribution of H.I.V. Medications to Resume — for Now
-
Stat News
Super Bowl ad from Hims and Hers exploits a regulatory gray area
-
MIT Technology Review
Mice with two dads have been created using CRISPR
Jan 28, 2025
-
Financial Times
Robert Kennedy allies fear he is losing US Senate support
-
The Wall Street Journal
Drugmakers Show Restraint on Price Increases in New Trump Era
-
Bloomberg
Pfizer Dodges Challenge to Its Board in Battle With Starboard
-
AP News
CDC ordered to stop working with WHO immediately
Previous
